REFERENCES
1. Zhu Y, Wan L, Li W, et al. Recent advances on 2′-fucosyllactose: physiological properties, applications, and production approaches. Crit Rev Food Sci Nutr. 2022;62:2083-92.
2. Hill DR, Chow JM, Buck RH. Multifunctional benefits of prevalent HMOs: implications for infant health. Nutrients. 2021;13:3364.
3. Zhou W, Jiang H, Wang L, Liang X, Mao X. Biotechnological production of 2′-fucosyllactose: a prevalent fucosylated human milk oligosaccharide. ACS Synth Biol. 2021;10:447-58.
4. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22:1147-62.
5. Lordan C, Roche AK, Delsing D, et al. Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond. Microbiol Mol Biol Rev. 2024;88:e0009423.
6. Lee WH, Pathanibul P, Quarterman J, et al. Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli. Microb Cell Fact. 2012;11:48.
7. Lee YG, Jo HY, Lee DH, et al. De novo biosynthesis of 2′-fucosyllactose by bioengineered Corynebacterium glutamicum. Biotechnol J. 2024;19:e2300461.
8. Turroni F, Milani C, Ventura M, van Sinderen D. The human gut microbiota during the initial stages of life: insights from bifidobacteria. Curr Opin Biotechnol. 2022;73:81-7.
9. Gotoh A, Katoh T, Sakanaka M, et al. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci Rep. 2018;8:13958.
10. Locascio RG, Niñonuevo MR, Kronewitter SR, et al. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol. 2009;2:333-42.
11. Button JE, Autran CA, Reens AL, et al. Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics. Cell Host Microbe. 2022;30:712-25.e7.
12. Batta VK, Rao SC, Patole SK.
13. Dargenio VN, Cristofori F, Brindicci VF, et al. Impact of Bifidobacterium longum subspecies infantis on pediatric gut health and nutrition: current evidence and future directions. Nutrients. 2024;16:3510.
14. Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS.
15. Swanson KS, Gibson GR, Hutkins R, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687-701.
16. Mohanty D, Misra S, Mohapatra S, Sahu PS. Prebiotics and synbiotics: recent concepts in nutrition. Food Biosci. 2018;26:152-60.
17. Ebrahimi ZS, Nasli-Esfahani E, Nadjarzade A, Mozaffari-Khosravi H. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. J Diabetes Metab Disord. 2017;16:23.
18. Khalesi S, Johnson DW, Campbell K, et al. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis. Eur J Nutr. 2018;57:2037-53.
19. Tabrizi R, Moosazadeh M, Lankarani KB, et al. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob Proteins. 2018;10:329-42.
20. Gomez Quintero DF, Kok CR, Hutkins R. The future of synbiotics: rational formulation and design. Front Microbiol. 2022;13:919725.
21. Ranadheera C, Vidanarachchi J, Rocha R, Cruz A, Ajlouni S. Probiotic delivery through fermentation: dairy vs. non-dairy beverages. Fermentation. 2017;3:67.
22. Chan CKY, Tao J, Chan OS, Li HB, Pang H. Preventing respiratory tract infections by synbiotic interventions: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2020;11:979-88.
23. Li F, Tai L, Sun X, et al. Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3. Cell Res. 2024;34:323-6.
24. Zierer J, Jackson MA, Kastenmüller G, et al. The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018;50:790-5.
25. Day-Walsh P, Shehata E, Saha S, et al. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota. Eur J Nutr. 2021;60:3987-99.
26. Arias N, Arboleya S, Allison J, et al. The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases. Nutrients. 2020;12:2340.
27. Lee DH. Development of synbiotics with 2′-fucosyllactose and Bifidobacterium spp. and analysis of their prebiotic effects. Cheongju: Chungbuk National University; 2022. Available from: https://chungbuk.dcollection.net/srch/srchDetail/200000771040. [Last accessed on 21 Jul 2025].
28. Minekus M, Alminger M, Alvito P, et al. A standardised static in vitro digestion method suitable for food - an international consensus. Food Funct. 2014;5:1113-24.
29. Gnoth MJ, Kunz C, Kinne-Saffran E, Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J Nutr. 2000;130:3014-20.
30. Seong H, Bae J, Seo JS, Kim S, Kim T, Han NS. Comparative analysis of prebiotic effects of seaweed polysaccharides laminaran, porphyran, and ulvan using in vitro human fecal fermentation. J Funct Foods. 2019;57:408-16.
31. Klindworth A, Pruesse E, Schweer T, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:e1.
32. Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57-9.
33. Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852-7.
34. Chong J, Liu P, Zhou G, Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15:799-821.
35. Baek H, Kim S, Min W, et al. A species-specific qPCR method for enumeration of Lactobacillus sanfranciscensis, Lactobacillus brevis, and Lactobacillus curvatus during cocultivation in sourdough. Food Anal Methods. 2021;14:750-60.
36. Bo B, Seong H, Kim G, Han NS. Antioxidant and prebiotic activities of Laphet, fermented tea leaves in Myanmar, during in vitro gastrointestinal digestion and colonic fermentation. J Funct Foods. 2022;95:105193.
37. Valero-Cases E, Cerdá-Bernad D, Pastor JJ, Frutos MJ. Non-dairy fermented beverages as potential carriers to ensure probiotics, prebiotics, and bioactive compounds arrival to the gut and their health benefits. Nutrients. 2020;12:1666.
38. McConnell RE, Benesh AE, Mao S, Tabb DL, Tyska MJ. Proteomic analysis of the enterocyte brush border. Am J Physiol Gastrointest Liver Physiol. 2011;300:G914-26.
39. Jorba I, Mostert D, Hermans LHL, van der Pol A, Kurniawan NA, Bouten CVC.
40. Moon JS, Li L, Bang J, Han NS. Application of in vitro gut fermentation models to food components: a review. Food Sci Biotechnol. 2016;25:1-7.
41. Lee DH, Seong H, Chang D, et al. Evaluating the prebiotic effect of oligosaccharides on gut microbiome wellness using in vitro fecal fermentation. NPJ Sci Food. 2023;7:18.
42. Pujari R, Banerjee G. Impact of prebiotics on immune response: from the bench to the clinic. Immunol Cell Biol. 2021;99:255-73.
43. Sierra S, Lara-Villoslada F, Sempere L, Olivares M, Boza J, Xaus J. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe. 2010;16:195-200.
44. Lahti L, Salonen A, Kekkonen RA, et al. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ. 2013;1:e32.
45. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8:52.
46. Bazanella M, Maier TV, Clavel T, et al. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome. Am J Clin Nutr. 2017;106:1274-86.
47. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9:1021.
48. Ryan JJ, Monteagudo-Mera A, Contractor N, Gibson GR. Impact of 2′-fucosyllactose on gut microbiota composition in adults with chronic gastrointestinal conditions: batch culture fermentation model and pilot clinical trial findings. Nutrients. 2021;13:938.
49. Sela DA, Garrido D, Lerno L, et al.
50. Bunesova V, Lacroix C, Schwab C. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense. BMC Microbiol. 2016;16:248.
51. Kim DH, Chon JW, Kim H, et al. Detection and enumeration of lactic acid bacteria, acetic acid bacteria and yeast in Kefir grain and milk using quantitative real-time PCR. J Food Saf. 2015;35:102-7.
52. Matsuo Y, Komiya S, Yasumizu Y, et al. Full-length 16S rRNA gene amplicon analysis of human gut microbiota using MinION™ nanopore sequencing confers species-level resolution. BMC Microbiol. 2021;21:35.
53. Lawley B, Centanni M, Watanabe J, et al.
54. O’Brien CE, Meier AK, Cernioglo K, et al. Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year. Pediatr Res. 2022;91:627-36.
55. Xie Z, He W, Gobbi A, Bertram HC, Nielsen DS. The effect of in vitro simulated colonic pH gradients on microbial activity and metabolite production using common prebiotics as substrates. BMC Microbiol. 2024;24:83.
56. Valdés-Varela L, Ruas-Madiedo P, Gueimonde M.
57. Engelstoft MS, Park WM, Sakata I, et al. Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. Mol Metab. 2013;2:376-92.
58. Liu F, Li P, Chen M, et al. Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase Bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population. Sci Rep. 2017;7:11789.
59. Rath S, Heidrich B, Pieper DH, Vital M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome. 2017;5:54.
60. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6:e02481.
61. Wang H, Li S, Fang S, Yang X, Feng J. Betaine improves intestinal functions by enhancing digestive enzymes, ameliorating intestinal morphology, and enriching intestinal microbiota in high-salt stressed rats. Nutrients. 2018;10:907.
